Sucampo Pharmaceuticals
A public, American biopharmaceutical company focused on medical applications of a class of ion channel modulators called prostones. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
$1.2b (Public information from Dec 2017)
Bethesda Maryland (HQ)
Authorizing premium user...